Clinical trial
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After…
NCT00042289 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00042289 |
|---|---|
| Title | Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy |
| Official title | Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | atazanavir/cobicistat, darunavir/ritonavir dosage #1, darunavir/ritonavir dosage #2, darunavir/ritonavir dosage #3, elvitegravir/cobicistat, dolutegravir, tenofovir alafenamide fumarate (TAF), TAF w/cobicistat, TAF w/cobicistat or ritonavir, efavirenz and 47 more |
| Enrollment | 1,578 |
| Start date | Jun 9, 2003 |
| Primary completion | Sep 30, 2020 |
| Completion | Sep 30, 2020 |
| First posted | Aug 1, 2002 |
| Last update posted | Dec 2, 2025 |
| Countries | Argentina, Botswana, Brazil, Puerto Rico, South Africa, Tanzania, Thailand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: